Author network for David Kunke by COREMINE medical

Publications in press

Hviid CV, Samulin Erdem J, Kunke D, Ahmed SM, Kjeldsen SF, Wang YY, Attramadal H, Aasen AO
The matri-cellular proteins 'cysteine-rich, angiogenic-inducer, 61' and 'connective tissue growth factor' are regulated in experimentally-induced sepsis with multiple organ dysfunction
Innate Immun (in press)
PubMed 22334618

Publications 2011

Sejersted Y, Hildrestrand GA, Kunke D, Rolseth V, Krokeide SZ, Neurauter CG, Suganthan R, Atneosen-Åsegg M, Fleming AM, Saugstad OD, Burrows CJ, Luna L, Bjørås M (2011)
Endonuclease VIII-like 3 (Neil3) DNA glycosylase promotes neurogenesis induced by hypoxia-ischemia
Proc Natl Acad Sci U S A, 108 (46), 18802-7
PubMed 22065741

Wang W, Esbensen Y, Kunke D, Suganthan R, Rachek L, Bjørås M, Eide L (2011)
Mitochondrial DNA damage level determines neural stem cell differentiation fate
J Neurosci, 31 (26), 9746-51
PubMed 21715639

Publications 2009

Kunke D, Bryja V, Mygland L, Arenas E, Krauss S (2009)
Inhibition of canonical Wnt signaling promotes gliogenesis in P0-NSCs
Biochem Biophys Res Commun, 386 (4), 628-33
PubMed 19545542

Publications 2007

Hildrestrand GA, Diep DB, Kunke D, Bolstad N, Bjørås M, Krauss S, Luna L (2007)
The capacity to remove 8-oxoG is enhanced in newborn neural stem/progenitor cells and decreases in juvenile mice and upon cell differentiation
DNA Repair (Amst), 6 (6), 723-32
PubMed 17236821

Publications 2005

Lorico A, Bratbak D, Meyer J, Kunke D, Krauss S, Plott WE, Solodushko V, Baum C, Fodstad O, Rappa G (2005)
Gamma-glutamylcysteine synthetase and L-buthionine-(S,R)-sulfoximine: a new selection strategy for gene-transduced neural and hematopoietic stem/progenitor cells
Hum Gene Ther, 16 (6), 711-24
PubMed 15960602

Publications 2004

Rappa G, Kunke D, Holter J, Diep DB, Meyer J, Baum C, Fodstad O, Krauss S, Lorico A (2004)
Efficient expansion and gene transduction of mouse neural stem/progenitor cells on recombinant fibronectin
Neuroscience, 124 (4), 823-30
PubMed 15026123

Publications 2003

Janousková O, Síma P, Kunke D (2003)
Combined suicide gene and immunostimulatory gene therapy using AAV-mediated gene transfer to HPV-16 transformed mouse cell: decrease of oncogenicity and induction of protection
Int J Oncol, 22 (3), 569-77
PubMed 12579310

Jinoch P, Zak R, Janousková O, Kunke D, Rittich S, Duskova M, Sobotkova E, Marinov I, Andelova M, Smahel M, Vonka V (2003)
Immunization with live HPV-16-transformed mouse cells expressing the herpes simplex thymidine kinase and either GM-CSF or IL-2
Int J Oncol, 23 (3), 775-83
PubMed 12888917

Publications 2000

Kunke D, Grimm D, Denger S, Kreuzer J, Delius H, Komitowski D, Kleinschmidt JA (2000)
Preclinical study on gene therapy of cervical carcinoma using adeno-associated virus vectors
Cancer Gene Ther, 7 (5), 766-77
PubMed 10830724

Publications 1996

Nemecková S, Sroller V, Kunke D, Krystofová J, Kutinová L (1996)
Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus
Acta Virol, 40 (5-6), 273-9
PubMed 9171455

Publications 1995

Kutinová L, Ludvíková V, Simonová V, Otavová M, Krystofová J, Hainz P, Press M, Kunke D, Vonka V (1995)
Search for optimal parent for recombinant vaccinia virus vaccines. Study of three vaccinia virus vaccinal strains and several virus lines derived from them
Vaccine, 13 (5), 487-93
PubMed 7639016

Publications 1994

Kutinová L, N?mecková S, Hamsíková E, Závadová H, Ludvíková V, Broucek J, Kunke D, König J, Zakharova LG, Pashvykina GV (1994)
Hepatitis B virus proteins expressed by recombinant vaccinia viruses: influence of preS2 sequence on expression surface and nucleocapsid proteins in human diploid cells
Arch Virol, 134 (1-2), 1-15
PubMed 8279947

N?mecková S, Kunke D, Press M, N?mecek V, Kutinová L (1994)
A carboxy-terminal portion of the preS1 domain of hepatitis B virus (HBV) occasioned retention in endoplasmic reticulum of HBV envelope proteins expressed by recombinant vaccinia viruses
Virology, 202 (2), 1024-7
PubMed 8030203

N?mecková S, Kutinová L, Kunke D, Schramlová J, Vonka V (1994)
[Construction of recombinant vaccinia viruses]
Cas Lek Cesk, 133 (24), 768-70
PubMed 7834680

Publications 1993

Kunke D, Broucek J, Kutinová L, N?mecková S, Ludvíková V, Strnad I, Kramosil J, Nemcová J, Schramlová J, Simonová V (1993)
Vaccinia virus recombinants co-expressing hepatitis B virus surface and core antigens
Virology, 195 (1), 132-9
PubMed 8317089

Publications 1992

Kutinová L, N?mecková S, Ludvíková V, Kunke D, Otavová M, Vonka V (1992)
[Problems associated with the development of vaccines based on recombinant vaccinia virus]
Cas Lek Cesk, 131 (24-25), 770-3
PubMed 1288884

Publications 1991

Ludvíková V, Kunke D, Hamsíková E, Kutinová L, Vonka V (1991)
Immunogenicity in mice of varicella-zoster virus glycoprotein I expressed by a vaccinia virus-varicella-zoster virus recombinant
J Gen Virol, 72 ( Pt 6), 1445-9
PubMed 1646285

N?mecková S, Kutinová L, Hamsíková E, Kunke D, Press M, Závadová H, Smrt J, Vonka V (1991)
Synthesis and immunogenicity of hepatitis B virus envelope antigen expressed by recombinant vaccinia virus. Finding of retention signal in the C-terminal portion of the preS1 domain of subtype adyw
Arch Virol, 121 (1-4), 29-41
PubMed 1759909